查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1738268

生物電子醫藥市場－全球產業規模、佔有率、趨勢、機會和預測（按類型、產品、應用、最終用戶、地區和競爭細分，2020-2030 年）

Bioelectronic Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Type, By Product, By Application, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球生物電子醫療市場價值為 235.4 億美元，預計到 2030 年將達到 335.9 億美元，預測期內的複合年成長率為 6.10%。市場成長的動力來自於心血管和神經系統疾病等慢性疾病的先進醫療解決方案日益成長的需求。政府對生物電子療法開發的支持和投資不斷增加，正在推動全球生物電子療法的採用。此外，隨著科技在醫療保健領域的進一步融合，心律調節器和除顫器等設備的使用正變得越來越普遍。人們越來越意識到這些設備的好處，例如減少副作用和改善患者治療效果，這進一步加速了需求。這些因素，再加上可支配收入的增加和人口老化加劇，預計將維持全球生物電子醫療市場的上升趨勢。

市場概覽
預測期 2026-2030
2024年市場規模 235.4億美元
2030年市場規模 335.9億美元
2025-2030 年複合年成長率 6.10%
成長最快的領域 迷走神經刺激器
最大的市場 北美洲

關鍵市場促進因素

慢性病盛行率上升和人口老化

主要市場挑戰

高成本和有限的報銷政策

主要市場趨勢

與數位健康和​​人工智慧的融合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：臨床試驗分析

第6章：全球生物電子醫學市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按類型（植入式、非侵入式）
    • 依產品（植入式心臟復律去顫器、心臟節律器、人工耳蝸、脊髓刺激器、深部腦部刺激器、經皮電神經刺激器、薦神經刺激器、迷走神經刺激器、其他）
    • 依應用（心律不整、疼痛管理、感音神經性聽損、巴金森氏症、震顫、憂鬱症、難治性憂鬱症、癲癇、尿失禁和大便失禁、其他）
    • 按最終使用者（醫院、個人使用者、家庭護理中心、門診手術中心、專科診所、其他）
    • 按地區（北美、歐洲、亞太、南美、中東和非洲）
    • 按公司分類（2024）
  • 市場地圖
    • 按產品
    • 按應用
    • 依技術
    • 按來源
    • 按地區

第7章：北美生物電子醫療市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第8章：歐洲生物電子醫學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第9章：亞太生物電子醫藥市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第10章：南美洲生物電子醫學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 11 章：中東和非洲生物電子醫學市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 12 章：市場動態

  • 驅動程式
  • 挑戰

第13章：市場趨勢與發展

  • 最新動態
  • 併購
  • 產品發布

第 14 章：全球生物電子醫療市場：SWOT 分析

第 15 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 16 章：競爭格局

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • Soterix Medical Inc.
  • Bioinduction Ltd.
  • GiMer Medical
  • CEFALY
  • BioControl Medical

第 17 章：策略建議

第18章調查會社について,免責事項

簡介目錄
Product Code: 14426

The Global Bioelectronic Medicine Market was valued at USD 23.54 billion in 2024 and is projected to reach USD 33.59 billion by 2030, growing at a CAGR of 6.10% during the forecast period. Market growth is being driven by rising demand for advanced healthcare solutions for chronic illnesses such as cardiovascular and neurological disorders. Increasing governmental support and investments in the development of bioelectronic therapies are boosting global adoption. Additionally, with greater integration of technology in healthcare, the use of devices like pacemakers and defibrillators is becoming more widespread. The growing awareness of the benefits associated with these devices-such as reduced side effects and improved patient outcomes-further accelerates demand. These factors, coupled with rising disposable incomes and a growing aging population, are expected to sustain the upward trajectory of the bioelectronic medicine market globally.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 23.54 Billion
Market Size 2030USD 33.59 Billion
CAGR 2025-20306.10%
Fastest Growing SegmentVagus Nerve Stimulators
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Chronic Diseases and Aging Population

The increasing global burden of chronic diseases-such as cardiovascular ailments, diabetes, and neurological disorders-is significantly contributing to the expansion of the bioelectronic medicine market. These long-term conditions often require continuous and targeted treatment approaches. Bioelectronic medicine, which includes technologies like pacemakers and neurostimulators, offers precise and less invasive alternatives to conventional pharmaceuticals. According to WHO, cardiovascular diseases account for nearly 17.9 million deaths annually, making them the leading cause of mortality worldwide. Similarly, the International Diabetes Federation estimated that 537 million adults lived with diabetes in 2021-a figure projected to grow to 643 million by 2030. This trend is further compounded by global demographic shifts, with one in six individuals expected to be over 65 by 2050. These factors collectively emphasize the need for reliable and innovative bioelectronic interventions, especially among elderly populations who are more vulnerable to chronic illnesses and adverse drug reactions.

Key Market Challenges

High Costs and Limited Reimbursement Policies

Despite its therapeutic potential, the bioelectronic medicine market faces challenges related to the high cost of devices and limited reimbursement coverage. Advanced implantable devices such as neurostimulators and defibrillators involve complex manufacturing processes and high R&D investments, resulting in substantial costs. In low- and middle-income countries, these high prices often place such treatments out of reach for a significant portion of the population. Furthermore, reimbursement frameworks for bioelectronic therapies are inconsistent across regions. In many cases, insurance does not fully cover the cost of treatment, making it financially burdensome for patients. WHO data shows that out-of-pocket medical expenses push approximately 100 million people into extreme poverty every year. These economic constraints hinder wider adoption and market penetration of bioelectronic medical solutions, especially in developing healthcare systems.

Key Market Trends

Integration with Digital Health and Artificial Intelligence

A major trend shaping the bioelectronic medicine market is the integration of digital health technologies and artificial intelligence (AI). AI is enhancing the precision and effectiveness of bioelectronic therapies by enabling real-time analysis of patient data and supporting personalized treatment protocols. Wearable bioelectronic devices are increasingly being used for continuous health monitoring, allowing for early intervention and proactive care. Government bodies are actively promoting these digital advancements. For example, the U.S. Department of Health and Human Services supports the adoption of AI in healthcare to improve efficiency and patient outcomes. Similarly, the European Commission's strategy for digital health encourages the implementation of smart medical technologies. The convergence of AI, data analytics, and bioelectronic medicine is paving the way for next-generation diagnostics and therapeutics, while also facilitating remote care and expanding access to treatment.

Key Market Players

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • Soterix Medical Inc.
  • Bioinduction Ltd.
  • GiMer Medical
  • CEFALY
  • BioControl Medical

Report Scope:

In this report, the Global Bioelectronic Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bioelectronic Medicine Market, By Type:

  • Implantable
  • Non-invasive

Bioelectronic Medicine Market, By Product:

  • Implantable cardioverter defibrillators
  • Cardiac pacemakers
  • Cochlear implants
  • Spinal cord stimulators
  • Deep brain stimulators
  • Transcutaneous electrical nerve stimulators
  • Sacral nerve stimulators
  • Vagus nerve stimulators
  • Others

Bioelectronic Medicine Market, By Application:

  • Arrhythmia
  • Pain management
  • Sensorineural hearing loss
  • Parkinson's disease
  • Tremor
  • Depression
  • Treatment-resistant depression
  • Epilepsy
  • Urinary and fecal incontinence
  • Others

Bioelectronic Medicine Market, By End User:

  • Hospitals
  • Individual Users
  • Homecare Centers
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

Bioelectronic Medicine Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bioelectronic Medicine Market.

Available Customizations:

Global Bioelectronic Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Type
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Bioelectronic Medicine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Implantable, Non-invasive)
    • 6.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
    • 6.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
    • 6.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
    • 6.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 6.2.6. By Company (2024)
  • 6.3. Market Map
    • 6.3.1. By Product
    • 6.3.2. By Application
    • 6.3.3. By Technique
    • 6.3.4. By Source
    • 6.3.5. By Region

7. North America Bioelectronic Medicine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Implantable, Non-invasive)
    • 7.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
    • 7.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
    • 7.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Bioelectronic Medicine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Canada Bioelectronic Medicine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Mexico Bioelectronic Medicine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Bioelectronic Medicine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Implantable v/s Non-invasive)
    • 8.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
    • 8.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
    • 8.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Bioelectronic Medicine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Bioelectronic Medicine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Bioelectronic Medicine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Bioelectronic Medicine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Bioelectronic Medicine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Bioelectronic Medicine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Implantable v/s Non-invasive)
    • 9.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
    • 9.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
    • 9.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Bioelectronic Medicine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. India Bioelectronic Medicine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Japan Bioelectronic Medicine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Bioelectronic Medicine Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Product
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Bioelectronic Medicine Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Product
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Bioelectronic Medicine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Implantable v/s Non-invasive)
    • 10.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
    • 10.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
    • 10.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Bioelectronic Medicine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Bioelectronic Medicine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Bioelectronic Medicine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Bioelectronic Medicine Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type (Implantable v/s Non-invasive)
    • 11.2.2. By Product (Implantable cardioverter defibrillators, Cardiac pacemakers, Cochlear implants, Spinal cord stimulators, Deep brain stimulators, Transcutaneous electrical nerve stimulators, Sacral nerve stimulators, Vagus nerve stimulators, Others)
    • 11.2.3. By Application (Arrhythmia, Pain management, Sensorineural hearing loss, Parkinson's disease, Tremor, Depression, Treatment-resistant depression, Epilepsy, Urinary and fecal incontinence, Others)
    • 11.2.4. By End User (Hospitals, Individual Users, Homecare Centers, Ambulatory Surgical Centers, Specialty Clinics, Others)
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Bioelectronic Medicine Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Product
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Bioelectronic Medicine Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Product
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Bioelectronic Medicine Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Product
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Global Bioelectronic Medicine Market: SWOT Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Medtronic plc
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. Abbott Laboratories
  • 16.3. Boston Scientific Corporation
  • 16.4. Cochlear Ltd.
  • 16.5. LivaNova PLC
  • 16.6. Soterix Medical Inc.
  • 16.7. Bioinduction Ltd.
  • 16.8. GiMer Medical
  • 16.9. CEFALY
  • 16.10. BioControl Medical

17. Strategic Recommendations

18. About Us & Disclaimer